Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-69
SponsorAsfendiyarov Kazakh National Medical University

About this trial

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18 to 69 years.

Residents of 17 regions of Kazakhstan.

Willingness to participate and provide informed consent.

Disqualifiers

Age less than 18 years old or over 69 years old.

Failure to provide informed consent or incomplete participation in data collection procedures.

Trial population

The study population consists of 6,720 adult volunteers aged 18 to 69 years, residing across 17 regions of Kazakhstan. Participants are stratified by age and gender to ensure balanced representation within the following age groups: * 18-29 years * 30-44 years * 45-59 years * 60-69 years Each age group includes an equal proportion of men and women, ensuring gender balance. The selection follows a multistage cluster sampling design, incorporating various socioeconomic backgrounds and health statuses to enhance the generalizability of findings.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • Genetic: DNA analysis

    Other intervention

    Investigation of telomere length (TL) and DNA methylation level analysis

Treatment groups

6,720 Participants
are divided into 1 treatment group
Group A: The study includes 1 cohort divided into 4 age subgroups.1 intervention

Trial outcomes

Primary outcomes

1

Accuracy of Machine Learning Model for Predicting Biological Age

Evaluation of the model's performance (based on telomere length and DNA methylation) using Mean Absolute Error (MAE), Mean Squared Error (MSE), and R².

Time frame
Within 10 months from start of data collection
2

Accuracy of Reproductive Function Prediction Model

Development and validation of machine learning model to predict reproductive function using biomarkers. Model performance evaluated via MAE, MSE, and R².

Time frame
Within 10 months from start of data collection

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.